Hester Biosciences Statistics

Total Valuation

NSE:HESTERBIO has a market cap or net worth of INR 15.04 billion. The enterprise value is 17.23 billion.

Market Cap	15.04B
Enterprise Value	17.23B

Important Dates

The last earnings date was Friday, May 16, 2025.

Earnings Date	May 16, 2025
Ex-Dividend Date	Aug 22, 2024

Share Statistics

Current Share Class	8.51M
Shares Outstanding	n/a
Shares Change (YoY)	-4.65%
Shares Change (QoQ)	-18.43%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.68M

Valuation Ratios

The trailing PE ratio is 54.72.

PE Ratio	54.72
Forward PE	n/a
PS Ratio	4.77
PB Ratio	4.60
P/TBV Ratio	4.89
P/FCF Ratio	34.25
P/OCF Ratio	23.32
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.94, with an EV/FCF ratio of 39.22.

EV / Earnings	62.67
EV / Sales	5.47
EV / EBITDA	24.94
EV / EBIT	32.95
EV / FCF	39.22

Financial Position

The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.65.

Current Ratio	1.56
Quick Ratio	0.64
Debt / Equity	0.65
Debt / EBITDA	3.28
Debt / FCF	4.86
Interest Coverage	3.79

Financial Efficiency

Return on equity (ROE) is 9.16% and return on invested capital (ROIC) is 5.54%.

Return on Equity (ROE)	9.16%
Return on Assets (ROA)	4.58%
Return on Invested Capital (ROIC)	5.54%
Return on Capital Employed (ROCE)	9.12%
Revenue Per Employee	4.91M
Profits Per Employee	428,162
Employee Count	642
Asset Turnover	0.48
Inventory Turnover	1.21

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.03% in the last 52 weeks. The beta is 0.18, so NSE:HESTERBIO's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	+1.03%
50-Day Moving Average	1,641.49
200-Day Moving Average	2,139.41
Relative Strength Index (RSI)	50.77
Average Volume (20 Days)	9,743

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:HESTERBIO had revenue of INR 3.15 billion and earned 274.88 million in profits. Earnings per share was 33.89.

Revenue	3.15B
Gross Profit	2.27B
Operating Income	481.74M
Pretax Income	395.71M
Net Income	274.88M
EBITDA	649.76M
EBIT	481.74M
Earnings Per Share (EPS)	33.89

Full Income Statement

Balance Sheet

The company has 72.19 million in cash and 2.13 billion in debt, giving a net cash position of -2.06 billion.

Cash & Cash Equivalents	72.19M
Total Debt	2.13B
Net Cash	-2.06B
Net Cash Per Share	n/a
Equity (Book Value)	3.27B
Book Value Per Share	443.02
Working Capital	699.90M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 645.11 million and capital expenditures -205.91 million, giving a free cash flow of 439.20 million.

Operating Cash Flow	645.11M
Capital Expenditures	-205.91M
Free Cash Flow	439.20M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 71.96%, with operating and profit margins of 15.29% and 8.73%.

Gross Margin	71.96%
Operating Margin	15.29%
Pretax Margin	12.56%
Profit Margin	8.73%
EBITDA Margin	20.63%
EBIT Margin	15.29%
FCF Margin	13.94%

Dividends & Yields

This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 0.34%.

Dividend Per Share	6.00
Dividend Yield	0.34%
Dividend Growth (YoY)	-25.00%
Years of Dividend Growth	n/a
Payout Ratio	18.80%
Buyback Yield	4.65%
Shareholder Yield	4.99%
Earnings Yield	1.83%
FCF Yield	2.92%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a